TGR-1202

umbralisib · TG Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TGR-1202, covering 2020-02-26 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL [Phase 1]